Our findings in STZ-treated rats revealed a significant reduction in Ach levels, accompanied by an increase in AchE activity in the hippocampus, consistent with previous reports linking insulin dysfunction to cholinergic impairment and cognitive deficits (Dubey et al. 2020). The gene discussed is INS; the disease is Cognitive impairment.